Inhibition of phosphatases and increased Ca2+ channel activity by inositol hexakisphosphate

Science

Volumn 278, Issue 5337, 1997, Pages 471-474

  Larsson, Olof ^a   Barker, Christopher J ^a   Sjöholm, Åke ^a   Carlqvist, Håkan ^b   Michell, Robert H ^c   Bertorello, Alejandro ^a   Nilsson, Thomas ^a   Honkanen, Richard E ^d   Mayr, Georg W ^e   Zwiller, Jean ^f   Berggren, Per Olof ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d UNIVERSITY OF SOUTH ALABAMA   (United States)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; GLUCOSE; INSULIN; PHOSPHATASE; PHYTIC ACID;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; ENDOCRINE CELL; ENZYME INHIBITION; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

ANIMALIA;

EID: 0030667979     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.278.5337.471     Document Type: Article

References (37)

1. P. Arkhammar, T. Nilsson, P. Rorsman, P.-O. Berggren, J. Biol. Chem. 262, 5448 (1987).
2. P.-O. Berggren and O. Larsson, Biochem. Soc. Trans. 22, 12 (1994).
3. M. J. Berridge and R. F. Irvine, Nature 341, 197 (1989).
4. S. I. Walaas and P. Greengard, Pharmacol. Rev. 43, 229 (1991); W. A. Catterall, Annu. Rev. Biochem. 64, 493 (1995); O. Krizanova, Gen. Physiol. Biophys. 15, 79 (1996).
5. S. I. Walaas and P. Greengard, Pharmacol. Rev. 43, 229 (1991); W. A. Catterall, Annu. Rev. Biochem. 64, 493 (1995); O. Krizanova, Gen. Physiol. Biophys. 15, 79 (1996).
6. S. I. Walaas and P. Greengard, Pharmacol. Rev. 43, 229 (1991); W. A. Catterall, Annu. Rev. Biochem. 64, 493 (1995); O. Krizanova, Gen. Physiol. Biophys. 15, 79 (1996).
7. C. Haby et al., Biochem. J. 298, 341 (1994).
8. C. Ämmälä et al., Proc. Natl. Acad. Sci. U.S.A. 91, 4343 (1994).
9. C. J. Barker and P.-O. Berggren, unpublished data.
10. 4 (buffer B) (0% B from 0 to 5 min, then a linear gradient to 100% B from 5 to 25 min, then 100% B from 25 to 55 min). Samples were collected with a Gilson 202 programmable fraction collector at 0.5-min intervals. Scintillation fluid (Scintillant Ultima Flo AP, Canberra Packard, Groningen, Netherlands) was added to the fractions, and radioactivity was determined by counting with quench correction.
11. P. J. Hughes and R. H. Michell, Curr. Opin. Neurobiol. 3, 383 (1993).
12. Å. Sjöholm, R. E. Honkanen, P.-O. Berggren, Biosci. Rep. 13, 349 (1993).
13. G. Li et al., J. Biol. Chem. 267, 4349 (1991).
14. 32P]phosphohistone, and the appropriate concentrations of inositol polyphosphates or derivatives. After 10 min of incubation at 30°C, 0.1 ml of 14% TCA was added, and the mixture was centrifuged for 5 min at 12,000g. The radioactivity was determined in a 0.1-ml portion of the supernatant.
15. C. Bialojan and A. Takai, Biochem. J. 256, 283 (1988); P. Cohen, C. F. B. Holmes, Y. Tsukitani, Trends Biochem. Sci. 15, 98 (1990); R. E. Honkanen et al., J. Biol. Chem. 266, 6614 (1991).
16. C. Bialojan and A. Takai, Biochem. J. 256, 283 (1988); P. Cohen, C. F. B. Holmes, Y. Tsukitani, Trends Biochem. Sci. 15, 98 (1990); R. E. Honkanen et al., J. Biol. Chem. 266, 6614 (1991).
17. C. Bialojan and A. Takai, Biochem. J. 256, 283 (1988); P. Cohen, C. F. B. Holmes, Y. Tsukitani, Trends Biochem. Sci. 15, 98 (1990); R. E. Honkanen et al., J. Biol. Chem. 266, 6614 (1991).
18. E. Graf, J. R. Mahoney, R. G. Bryant, J. W. Eaton, J. Biol. Chem. 259, 3620 (1987); P. T. Hawkins et al., Biochem. J. 294, 929 (1993); I. D. Spiers et al., Carbohydr. Res. 282, 81 (1996).
19. E. Graf, J. R. Mahoney, R. G. Bryant, J. W. Eaton, J. Biol. Chem. 259, 3620 (1987); P. T. Hawkins et al., Biochem. J. 294, 929 (1993); I. D. Spiers et al., Carbohydr. Res. 282, 81 (1996).
20. E. Graf, J. R. Mahoney, R. G. Bryant, J. W. Eaton, J. Biol. Chem. 259, 3620 (1987); P. T. Hawkins et al., Biochem. J. 294, 929 (1993); I. D. Spiers et al., Carbohydr. Res. 282, 81 (1996).
21. D. L. Brautigan and C. L. Shriner, Methods Enzymol. 159, 339 (1988).
22. J. Zwiller and P.-O. Berggren, unpublished data.
23. A. B. Theibert et al., Proc. Natl. Acad. Sci. U.S.A. 88, 3165 (1991).
24. M. Fukada, J. Aruga, M. Niinobe, S. Aimoto, K. Mikoshiba, J. Biol. Chem. 269, 29206 (1994).
25. K. Nogimori et al., ibid. 266, 16499 (1991).
26. J. A. Stuart, K. L. Anderson, P. J. French, C. J. Kirk, R. H. Michell, Biochem. J. 303, 517 (1994); D. Carpenter et al., Biochem. Soc. Trans. 17, 3 (1989).
27. J. A. Stuart, K. L. Anderson, P. J. French, C. J. Kirk, R. H. Michell, Biochem. J. 303, 517 (1994); D. Carpenter et al., Biochem. Soc. Trans. 17, 3 (1989).
28. 2, 10 mM EGTA, 3 mM Mg-ATP, and 5 mM Hepes (pH 7.15). All experiments were performed at room temperature (22° to 24°C). The whole-cell configuration of the patch-clamp technique [O. P. Hamill, A. Marty, E. Neher, B. Sakmann, F. J. Sigworth, Pfluegers Arch. Eur. J. Physiol. 391, 85 (1981)] was used with an Axopatch 200 patch-clamp amplifier (Axon Instruments). Voltage steps were generated, digitized, and stored with the program pClamp (Axon Instruments) and Labmaster ADC (Scientific Solutions, Solon, OH). The current responses were filtered at 1 kHz with a Bessel filter (-3-dB point).
29. F. M. Ashcroft and P. Rorsman, Prog. Biophys. Mol. Biol. 54, 87 (1989).
30. R. W. Tsien, D. Lipscombe, D. V. Madison, K. R. Bley, A. P. Fox, Trends Neurosci. 11, 431 (1988).
31. O. Larsson and P.-O. Berggren, unpublished data.
32. F. S. Menniti, K. G. Oliver, J. W. J. Putney, S. B. Shears, Trends Biochem. Sci. 18, 53 (1993).
33. C. J. Barker et al., Biochem. J. 306, 557 (1995).
34. A. M. Efanov, S. V. Zaitsev, P.-O. Berggren, Proc. Natl. Acad. Sci. U.S.A. 94, 4435 (1997).
35. R. H. Palmer et al., J. Biol. Chem. 270, 22412 (1995).
36. D. R. Poyner, F. Cooke, M. R. Hanley, D. J. Reynolds, P. T. Hawkins, ibid. 268, 1032 (1993).
37. We thank M. O. Revel for preparation of purified PP1, PP2A, and PP3 and A. Lindgren for technical assistance. Supported by the Swedish Medical Research Council (grants 03x-09890, 04x-09891, and 19x-00034), the Funds of the Karolinska Institute, the Juvenile Diabetes Foundation International, the Nordic Insulin Foundation, the Magnus Bergvalls Foundation, the Swedish Diabetes Association, the Bert von Kantzows Foundation, the Fredrik and Ingrid Thurings Foundation, and the Association pour la Recherche sur le Cancer (5039) and by grants from the Swedish Medical Research Council, the Swedish Institute, the Karolinska Institute, and the Swedish Diabetes Association (C.J.B. and J.Z.).